New approach to breast cancer detection using synchrotron radiation
Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.
Showing 461 - 480 of 480 results
Phase contrast tomography shows great promise in early stages of study and is expected to be tested on first patients by 2020.
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
The mechanical, electrical, chemical, optical and thermal properties of glass, as determined by its chemical composition and atomic structure, make it a highly useful material with a myriad of applications.
Beamtime guide on the SAX / WAXS beamline at the Australian Synchrotron.
As an experimental tool for the study of magnetism, neutron scattering is without equal in its range of applications.
In May 2023, The Honourable Dr Annabelle Bennett, ANSTO Board Chair, shared ANSTO's Statement of Intent with the Minister for Industry, Science and Technology.
Thirty years of ANSTO's unique capability in monitoring fine particle pollution provides insight on bushfire smoke.
Bushfires in proximity to ANSTO during the 2018 bushfires.
On the 9th of December 2022, the Minister for Industry, Science and Technology provided his Statement of Expectations to ANSTO.
Frequently asked questions about beamtime, accommodation and the user portal.
3D models of multilayered structures on engineering scale from nanoscale damage profiles.
ANSTO commenced an aerosol sampling program thirty years ago this week to characterise these pollutants and ultimately, identify their sources, which has taken it to the forefront of environmental monitoring of this type in Australia and the region.
Frequently Asked Questions on the Macromolecular Crystallography beamlines (MX1 and MX2)
Publications and resources from the Powder Diffraction beamline.
Highlights of the Magnetism Project.